Drug intelligence / Profile preview

DK-004

Development stage: Preclinical
Lead developer: Carephar

Overview

DK-004 is an investigational drug candidate currently in preclinical development by Nanjing Carephar Pharmaceutical (also known as Jiangsu Carephar Pharmaceutical Co., Ltd.). It is being developed for the treatment of musculoskeletal disorders, specifically knee osteoarthritis. Technical details regarding its chemical structure, biological target, and specific mechanism of action remain proprietary and have not been publicly disclosed by the developer. The program is in the early research stages with minimal technical information available in the public domain.

Beyond the preview

Go deeper on DK-004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DK-004.

Explore the full profile